Characterization of Bcl10 as a potential transcriptional activator that interacts with general transcription factor TFIIB

Biochemical and Biophysical Research Communications

Volumn 320, Issue 1, 2004, Pages 1-6

  Liu, Yingle ^a   Dong, Wei ^a   Chen, Lu ^a   Zhang, Peng ^a   Qi, Yipeng ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Bcl10; TFIIB; Transcriptional activator

Indexed keywords

HYBRID PROTEIN; PROTEIN BCL 10; TRANSCRIPTION FACTOR GAL4; TRANSCRIPTION FACTOR IIB;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA BINDING; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE MAPPING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MAMMAL CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR TFIIB; TRANSCRIPTION FACTORS, GENERAL;

MAMMALIA;

EID: 2942650120     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.05.112     Document Type: Article

References (22)

1. Willis T.G., Jadayel D.M., Du M., Peng H., Perry A.R., Abdul-Rauf M., Price H., Karran L., Majekodunmi O., Wlodarska I., Pan L., Crook T., Hamoudi R., Isaacson P.G., Dyer M.J.S. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 96:1999;35-45
2. Zhang Q., Siebert R., Yan M., Hinzmann B., Cui X., Xue L., Rakestraw K.M., Naeve C.W., Beckmann G., Weisenburger D.D., Sanger W.G., Nowotny H., Vesely M., Callet-Bauchu E., Salles G., Dixit V.M., Rosenthal A., Schlegelberger B., Morris S.W. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat. Genet. 22:1999;63-68
3. Ruland J., Duncan G.S., Elia A., del Barco Barrantes I., Nguyen L., Plyte S., Millar D.G., Bouchard D., Wakeham A., Ohashi P.S., Mak T.W. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell. 104:2001;33-42
4. Xue L., Morris S.W., Orihuela C., Tuomanen E., Cui X., Wen R., Wang D. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Nat. Immunol. 4:2003;857-865
5. Du M.Q., Peng H., Liu H., Hamoudi R.A., Diss T.C., Willis T.G., Ye H., Dogan A., Wotherspoon A.C., Dyer M.J., Isaacson P.G. BCL10 gene mutation in lymphoma. Blood. 95:2000;3885-3890
6. Takahashi H., Maeda Y., Seto M., Hosokawa Y. Nucleotide insertions and deletions within the homopolymeric runs of adenines and thymidines of BCL10 cDNAs in normal peripheral blood leukocytes. Blood. 95:2000;2728-2729
7. Steinemann D., Siebert R., Harder S., Martin-Subero I., Kettwig G., Hinzmann B., Gesk S., Tiemann M., Merz H., Rosenthal A., Grote W., Morris S.W., Schlegelberger B. Frequent allelic loss of the BCL10 gene in lymphomas with the t(11;14)(q13;q32). Leukemia. 15:2001;474-475
8. Apostolou S., De Rienzo A., Murthy S.S., Jhanwar S.C., Testa J.R. Absence of BCL10 mutations in human malignant mesothelioma. Cell. 97:1999;684
9. Fakruddin J.M., Chaganti R.S., Murty V.V. Lack of BCL10 mutations in germ cell tumors and B cell lymphomas. Cell. 1999;683-684
10. Shen L., Liang A.C., Lu L., Au W.Y., Wong K.Y., Tin P.C., Chan K.W., Ko K.H., Chen Y.W., Beh S.L., Shimizu N., Tsuchiyama J., Tang J.C., Kwong Y.L., Liang R.H., Srivastava G. Aberrant BCL10 nuclear expression in nasal NK/T-cell lymphoma. Blood. 102:2003;1553-1554
11. Maes B., Demunter A., Peeters B., De Wolf-Peeters C. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression. Blood. 99:2002;1398-1404
12. Liu H., Ye H., Dogan A., Ranaldi R., Hamoudi R.A., Bearzi I., Isaacson P.G., Du M.Q. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood. 98:2001;1182-1187
13. Shen L., Liang A.C., Au W.Y., Lu L., Chen Y.W., Wong K.Y., Tang J.C., Chan K.W., Beh S.L., Kwong Y.L., Liang R.H., Srivastava G. BCL10 mutations are irrelevant to its aberrant nuclear localization in nasal NK/T-cell lymphoma. Leukemia. 2003;2240-2242
14. Harhaj E.W., Sun S.C. Regulation of relA subcellular localization by a putative nuclear export signal and p50. Mol. Cell. Biol. 19:1999;7088-7095
15. Birbach A., Gold P., Binder B.R., Hofer E., de Martin R., Schmid J.A. Signaling molecules of the NF-κB pathway shuttle constitutively between cytoplasm and nucleus. J. Biol. Chem. 277:2002;10842-10851
16. Verma U.N., Yamamoto Y., Prajapati S., Gaynor R.B. Nuclear role of IKKgamma /NEMO in NF-kappa B-dependent gene expression. J. Biol. Chem. 279:2004;3509-3515
17. Poyet J.L., Srinivasula S.M., Alnemri E.S. vCLAP, a caspase-recruitment domain-containing protein of Equine Herpesvirus-2, persistently activates the IkB kinases through oligomerization of IKKg. J. Biol. Chem. 276:2001;3183-3187
18. Chen M., Li L.Y., Qi Y.P. Bcl10 protein can act as a transcription activator in yeast. Mol. Cell. Biochem. 246:2003;97-103
19. Lin Y.S., Green M.R. Mechanism of action of an acidic transcriptional activator in vitro. Cell. 64:1991;971-981
20. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489
21. Ptashne M., Gann A. Transcriptional activation by recruitment. Nature. 386:1997;569-577
22. Woychik N.A., Hampsey M. The RNA polymerase II machinery: structure illuminates function. Cell. 108:2002;453-463